Cargando…
Intravitreal Bevacizumab for the Treatment of Neovascular Glaucoma Associated With Central Retinal Artery Occlusion
We report three cases of neovascular glaucoma secondary to central retinal artery occlusion (CRAO) which were effectively managed with intravitreal bevacizumab (IVB) followed by panretinal photocoagulation (PRP). Neovascular glaucoma without peripheral anterior synechiae developed between one and fi...
Autores principales: | Sagong, Min, Kim, Jinseon, Chang, Woohyok |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739969/ https://www.ncbi.nlm.nih.gov/pubmed/19794952 http://dx.doi.org/10.3341/kjo.2009.23.3.215 |
Ejemplares similares
-
Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report
por: Jeong, Seongyong, et al.
Publicado: (2017) -
Application of Intravitreal Bevacizumab for Circumscribed Choroidal Hemangioma
por: Sagong, Min, et al.
Publicado: (2009) -
Intravitreal Bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case report
por: Alasil, Tarek, et al.
Publicado: (2009) -
Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion
por: Lee, You Hyun, et al.
Publicado: (2022) -
Bilateral Serous Retinal Detachment as a Presenting Sign of Acute Lymphoblastic Leukemia
por: Kim, Jinseon, et al.
Publicado: (2010)